首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:European journal of preventive cardiology

缩写:EUR J PREV CARDIOL

ISSN:2047-4873

e-ISSN:2047-4881

IF/分区:10.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引5628
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Line H S Nielsen,Bertram Kjerulff,Camilla S Morgen et al. Line H S Nielsen et al.
Background and aims: Obesity is a major risk factor for hypertension, but most evidence relies on single weight measurements. We examined associations between weight change and short-term risk of incident hypertension acr...
Jeremy Florence,Trecy Gonçalves,Solenn Toupin et al. Jeremy Florence et al.
Aims: To characterize the cardiovascular magnetic resonance (CMR) phenotype of hypertensive hypertrophic cardiomyopathy (HCM) patients, assess the association between hypertension and all-cause mortality, and compare the ...
Yi-Zhou Peng,Zhao-Wei Zhu,Yue-Jiao Yang et al. Yi-Zhou Peng et al.
Background: Systemic inflammation has been implicated in valvular degeneration, but prospective evidence across major non-rheumatic valvular phenotypes remains limited. We investigated the associations of circulating infl...
Alberto Milanese,Antonio Giampiero Russo Alberto Milanese
Aims: To externally validate and compare CUORE and SCORE2 for 10-year prediction of first fatal or non-fatal myocardial infarction or stroke in an Italian primary care cohort, and to quantify the impact of administrative ...
Anagh Astavans,Derek Baughman,Nestoras Mathioudakis Anagh Astavans
Aims: Evidence characterizing major adverse cardiovascular and cerebrovascular (MACCE) risk in adult-onset type 1 diabetes (T1DM), particularly versus type 2 (T2DM), remains limited, inconsistent, and derived from non-U.S...
In Young Cho,Jin Hyung Jung,Seonyoung Kang et al. In Young Cho et al.
Aims: We investigated the risk of MI by RA status and seropositivity and performed exploratory analysis of biologic DMARD (bDMARD) and targeted synthetic DMARD (tsDMARD) use. ...